期刊文献+

复发性外阴阴道念珠菌病研究进展 被引量:2

下载PDF
导出
摘要 复发性外阴阴道念珠菌病(RVVC)是外阴阴道念珠菌病(VVC)的一种复杂形式,系指12个月中确实发作4次或4次以上有症状的VVC。据估计5%的成年妇女患有反复发作的顽固性念珠菌性外阴阴道炎,典型临床表现为外阴瘙痒和阴道分泌物增多,通过实验室检查、镜检加培养确诊为念珠菌感染。由于该病病因复杂,顽固难愈已成为临床医学的难点和研究热点,揭示其发病机制,明确影响复发的有关因素,将对其积极有效的防治有重要指导意义。现就近几年来对RVVC发病机制及防治的研究进展做简要阐述。
机构地区 泗水县人民医院
出处 《基层医学论坛》 2007年第12期1124-1126,共3页 The Medical Forum
  • 相关文献

参考文献4

  • 1刘军,刘维达.系统性真菌病的免疫治疗[J].国外医学(皮肤性病学分册),2005,31(3):174-176. 被引量:2
  • 2陈辉,刘维达.新型抗真菌药物卡泊芬净及其在临床的应用[J].国外医学(皮肤性病学分册),2005,31(1):9-11. 被引量:18
  • 3Claudia Maria Leite Maffei,Claudete Rodrigues Paula,Tereza S?nia Mazzocato,Sílvio Franceschini. Phenotype and genotype of Candida albicans strains isolated from pregnant women with recurrent vaginitis[J] 1997,Mycopathologia(2):87~94
  • 4Dan Hellberg MD, PhD,Birgitta Zdolsek,Staffan Nilsson,Per-Anders M?rdh. Sexual behavior of women with repeated episodes of vulvovaginal candidiasis[J] 1995,European Journal of Epidemiology(5):575~579

二级参考文献61

  • 1Arathoon EG, Gotuzzo E, Noriega LM, et al. Randomized, doubleblind, muhicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother, 2002, 46:451 -457.
  • 2Colombo AL, Perfect J, DiNubile M, et al. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur J Clin Micmhinl lnf~c.t Di~ 9f~i 99./170--/17/1.
  • 3Garbino J, Lew D, Hirschel B, et al. Caspofungin in the treatment of oropharyngeal candidiasis. Int J Clin Pract, 2003, 57 : 143 - 144.
  • 4Debono M, Gordee RS. Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol, 1994, 48:471 -497.
  • 5Denning DW. Eehinocandin antifungal drugs. Lancet, 2003, 362:1142 - 1151.
  • 6Balani SK, Xu X, Arison BH, et al. Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine. Drug Metab Dispos, 2000, 28 : 1274 - 1278.
  • 7Pfaller MA, Diekema DJ, Messer SA, et al. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp. , including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother, 2003, 47:1068- 1071.
  • 8Ju JY, Polhamus C, Marr KA, et al. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47 phox-/-knockout mice. Antimicrob Agents Chemother, 2002, 46: 1240-1245.
  • 9Diekema DJ, Messer SA, Hollis RJ, et al. Activities of caspofungin,itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol, 2003, 41:3623- 3626.
  • 10Kirkpatrick WR, Perea S, Coco BJ, et al. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother, 2002, 46:2564- 2568.

共引文献17

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部